glp-1 news today 2025 november FDA bans compounded drugs November in review: GLP-1 breakthroughs,

A separate rapid review published in Obesity Reviews in late 2025 by Jebeile and colleagues, which analyzed 25 studies, found that binge eating episodes and prevalence were reduced following treatment with liraglutide and semaglutide

Shi et al., 2024)

Like the rest of Kinds lineup (which includes patches for sleep, stress, and focus), this is an over-the-counter supplement with no FDA approval, no prescription, and no clinical supervision

This study revealed a high prevalence of CVD risk factors among obese patients with IBD

With that said, pregnancy may contribute to additional regain

Skipping meals can cause your blood sugar to drop too low and can also increase the likelihood of not getting adequate vitamins and minerals throughout the day